Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Novavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines
10:45am, Friday, 10'th May 2024
Novavax (NVAX) shares more than doubled in intraday trading Friday after announcing a $1.2 billion deal to license its vaccine technology to French drugmaker Sanofi (SNY).
Vaccine Stock Explodes After Sanofi Deal
10:07am, Friday, 10'th May 2024
Novavax Inc (NASDAQ:NVAX) stock is up 130% to trade at $10.82 today, by far the best stock on the Nasdaq this morning.
Novavax Shares Surge Over 140% After $1.4 Billion Covid Shot Deal With Sanofi
09:41am, Friday, 10'th May 2024
Shares for Novavax swelled by more than 140% Friday morning, after the biotech firm announced a $1.4 billion deal with Sanofi to commercialize its Covid vaccine and develop a new combination shot for
Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates
08:06am, Friday, 10'th May 2024
Novavax (NVAX) came out with a quarterly loss of $1.05 per share versus the Zacks Consensus Estimate of a loss of $1.04. This compares to loss of $3.41 per share a year ago.
Novavax Gets $1.4 Billion Deal With Sanofi. The Stock Jumps.
06:47am, Friday, 10'th May 2024
The two companies will also work on a shot that combines Covid-19 and flu vaccines.
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses
05:53am, Friday, 10'th May 2024
Novavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the company's fiscal Q1 2024 earnings report but more significantly, by a crucial multi-billion dollar deal wi
Novavax shares surge on new $1.4 billion deal with Sanofi
05:00am, Friday, 10'th May 2024
Novavax on Friday said it had struck a $1.4 billion deal with Sanofi to commercialize its existing COVID-19 vaccine and develop a new combined jab to inoculate against both the coronavirus and influen
Novavax erases doubts about its ability to remain in business
02:39am, Friday, 10'th May 2024
COVID-19 vaccine maker Novavax , on Friday, erased doubts about its ability to remain in business by removing a so-called "going concern" notice.
France's Sanofi in COVID-19 vaccine deal with Novavax - statement
02:13am, Friday, 10'th May 2024
Sanofi on Friday announced it has reached a 'co-exclusive' licensing agreement with Novavax to sell a stand-alone COVID-19 vaccine and develop new flu-COVID-19 combination vaccines.
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shots
02:00am, Friday, 10'th May 2024
The deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having "substantial doubt" about its ability to survive.
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street Analysts
05:06am, Thursday, 09'th May 2024
Although Wall Street is captivated by the artificial intelligence (AI) revolution, Nvidia's upside may be limited. Select Wall Street analysts expect far superior returns from three high-risk/high-rew
Novavax (NVAX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:01am, Tuesday, 07'th May 2024
Novavax (NVAX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, 2024
09:25am, Tuesday, 07'th May 2024
GAITHERSBURG, Md. , May 7, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its first
Novavax's top shareholder Shah Capital ramps up efforts for board shakeup
08:18am, Monday, 06'th May 2024
Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the re-election of three directors and proposals related to executive compensation, ramping up its efforts for a board shak
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
07:15pm, Tuesday, 30'th Apr 2024
In the latest trading session, Novavax (NVAX) closed at $4.33, marking a +0.93% move from the previous day.
